A Rare Case of Community Acquired Cavitary Lung Disease Caused by Group F Streptococcus

Nishant Tripathi^1, , San Diego Warren¹ and Niki Koirala PharmD²

¹Brookdale University Hospital, Brooklyn, NY

²Covenant Medical Center, Waterloo, IA

Cite this paper:
Nishant Tripathi, San Diego Warren and Niki Koirala PharmD. A Rare Case of Community Acquired Cavitary Lung Disease Caused by Group F Streptococcus. American Journal of Medical Case Reports. 2017; 5(1):25-28. doi: 10.12691/ajmcr-5-1-7

Abstract

Many organisms previously considered non-pathogenic are the causative agents of many fatal diseases . Considered to be non-pathogenic, Group F streptococcus is increasingly being implicated in several disease conditions. Streptococcus F can have different forms of hemolysis and presence of carbohydrate antigens that are not routinely tested. As a result they might be wrongly classified as other type of Streptococci or dismissed as contaminant. Here we describe a rare presentation of Cavitary lung disease caused by Group F Streptococcus.

Keywords:
Streptococcus F caviatary lung disease

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Gossling J. Occurrence and pathogenicity of the Streptococcus milleri group. Rev Infect Dis 1988; 10:257.
[2]	Willcox MD, Knox KW. Surface-associated properties of Streptococcus milleri group strains and their potential relation to pathogenesis. J Med Microbiol 1990; 31:259.
[3]	Toyoda K, Kusano N, Saito A. Pathogenicity of the Streptococcus milleri group in pulmonary infections--effect on phagocytic killing by human polymorphonuclear neutrophils. Kansenshogaku Zasshi 1995; 69:308.
[4]	Nagamune H, Whiley RA, Goto T, et al. Distribution of the intermedilysin gene among the anginosus group streptococci and correlation between intermedilysin production and deep-seated infection with Streptococcus intermedius. J Clin Microbiol 2000; 38: 220.
[5]	Jacobs JA, Stobberingh EE. Hydrolytic enzymes of Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius in relation to infection. Eur J Clin Microbiol Infect Dis 1995; 14: 818.
[6]	Kitada K, Inoue M, Kitano M Experimental endocarditis induction and platelet aggregation by Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius. FEMS Immunol Med Microbiol 1997; 19: 25.
[7]	Clarridge JE, Attorri S Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus (“Streptococcus milleri group”) are of clinical importance and are not equally associated with abscess. Oxford Journal clinical infectious disease (2001) 32(10) 1511-1515.
[8]	Bohre R, Furth R Etiology of community acquired pneumonia: A prospective study among adults requiring admission to hospital Thorax British Medical Journal 1995: 50: 543-547.
[9]	Talan DA, Citron DM, Abrahamian FM, Morgan GJ, Goldstein EJ Bacteriologic analysis of infected dog and cat bites. N Eng J Med 1999 340: 85-92.
[10]	Mejare B, Edwardsson S Streptococcus Milleri: an indigenous organism of the human oral cavity. Arch Oral Biol. 1975: 20(11): 757.